Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1293-1297

  Savola, K ^a   Sabbah, E ^a   Kulmala, P ^a   Vahasalo P ^a   Ilonen, J ^b   Knip, M ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Clinical characteristics; GAD antibodies; HLA risk markers; IA 2 antibodies; Insulin autoantibodies; Islet cell antibodies

Indexed keywords

ANTIGEN; AUTOANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DR ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; DISEASE DURATION; FEMALE; GENETIC RISK; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; RISK ASSESSMENT; TIME FACTORS;

EID: 0031739110     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051067     Document Type: Article

References (11)

1. Knip M (1997) Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. Ann Med 29: 447-451
2. Savola K, Bonifacio E, Sabbah E et al. (1998) IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 41: 424-429
3. Kolb H, Dannehl K, Gruneklee D (1988) Prospective analysis of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes. Diabetologia 31: 189-194
4. 65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 20: 642-644
5. Muhr D, Mollenhauer U, Ziegler A-G, Haslbeck M, Standl E, Schnell O (1997) Autoantibodies to symphatetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care 20: 1009-1012
6. Bonifacio E, Genovese S, Braghi S et al. (1995) Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822
7. Karjalainen J, Knip M, Mustonen A, Åkerblom HK (1988) Insulin autoantibodies at the clinical manifestation of Type 1 (insulin-dependent) diabetes - a poor predictor of clinical course and antibody response to exogenous insulin. Diabetologia 31: 129-133
8. Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132-143
9. Lendrum R, Walker G, Cudworth AG et al. (1976) Islet-cell antibodies in diabetes mellitus. Lancet ii:1273-1276
10. Eizirik DL, Sandler S, Palmer JP (1993) Repair of pancreatic β-cells. A relevant phenomenon in early IDDM? Diabetes 42: 1383-1391
11. Swenne I (1992) Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 35: 193-201